Conclusion
The inaugural meeting of the European CINV Forum has provided insight into areas of both commonality and difference between the countries represented, and generated a range of recommendations for improving the management of CINV.
First and foremost among these recommendations is that the CINV risk for every patient should be assessed before chemotherapy is administered,and appropriate prophylactic measure should be taken, based on the latest guidelines. However,we believe that the formation of the forum and our commitment to ongoing discussions and activity will help to improve cross-border communication of knowledge, idea and good practice, and raise the profile of an evidence -based approach to CINV management.